NCT00375206View on ClinicalTrials.gov

A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine

PHASE1CompletedINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

January 31, 2007

Conditions

Influenza

Interventions

BIOLOGICAL

Trivalent DNA Vaccine (PIA0601) with or without DEI-LT (pPJV2012)

Trial Locations (2)

65802

Biokinetic, Springfield

66219

Quintiles Lenexa (QLX), Lenexa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

PowderMed

INDUSTRY